Economic costs of acamprosate treatment among alcohol-dependent patients initiating an abstinence program

被引：0
|
作者：
Erder, MH
Weycker, D
Oster, G
机构：
[1] Forest Labs Inc, New York, NY USA
[2] Policy Anal Inc, Brookline, MA USA
来源：
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | 2005年 / 29卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页码：172A / 172A
页数：1
相关论文
共 50 条
  • [1] Acamprosate promotes abstinence in alcohol-dependent patients who relapse during treatment
    Schneider, E
    Saikali, K
    Zhang, DZ
    Gage, A
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 29 (05) : 160A - 160A
  • [2] Economic evaluation of Campral® (Acamprosate) compared to placebo in maintaining abstinence in alcohol-dependent patients
    Annemans, L
    Vanoverbeke, N
    Tecco, J
    D'Hooghe, D
    EUROPEAN ADDICTION RESEARCH, 2000, 6 (02) : 71 - 78
  • [3] Acamprosate facilitates the maintenance of abstinence in alcohol-dependent patients after alcohol withdrawal
    不详
    Drugs & Therapy Perspectives, 2006, 22 (3) : 1 - 4
  • [4] Efficacy of acamprosate in regaining abstinence in alcohol-dependent patients who relapse
    Schneider, Eugene
    Saikali, K.
    Zhang, D.
    Gage, A.
    AMERICAN JOURNAL ON ADDICTIONS, 2006, 15 (04): : 319 - 319
  • [5] A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol-dependent patients
    Weinstein, A
    Feldtkeller, B
    Feeney, A
    Lingford-Hughes, A
    Nutt, DJ
    ADDICTION BIOLOGY, 2003, 8 (02) : 229 - 232
  • [6] Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate
    V M Karpyak
    J M Biernacka
    J R Geske
    G D Jenkins
    J M Cunningham
    J Rüegg
    O Kononenko
    A A Leontovich
    O A Abulseoud
    D K Hall-Flavin
    L L Loukianova
    T D Schneekloth
    M K Skime
    J Frank
    M M Nöthen
    M Rietschel
    F Kiefer
    K F Mann
    R M Weinshilboum
    M A Frye
    D S Choi
    Translational Psychiatry, 2014, 4 : e453 - e453
  • [7] Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate
    Karpyak, V. M.
    Biernacka, J. M.
    Geske, J. R.
    Jenkins, G. D.
    Cunningham, J. M.
    Rueegg, J.
    Kononenko, O.
    Leontovich, A. A.
    Abulseoud, O. A.
    Hall-Flavin, D. K.
    Loukianova, L. L.
    Schneekloth, T. D.
    Skime, M. K.
    Frank, J.
    Noethen, M. M.
    Rietschel, M.
    Kiefer, F.
    Mann, K. F.
    Weinshilboum, R. M.
    Frye, M. A.
    Choi, D. S.
    TRANSLATIONAL PSYCHIATRY, 2014, 4 : e462 - e453
  • [8] Treatment of alcohol-dependent outpatients with acamprosate: A clinical review
    Mason, BJ
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 : 42 - 48
  • [9] The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: Results of a meta-analysis
    Mann, K
    Lehert, P
    Morgan, MY
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (01) : 51 - 63
  • [10] In recently detoxified alcohol-dependent adults, acamprosate increases abstinence maintenance and reduces dropout
    Pal, Hemraj
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (05) : JC51 - JC51
12345